imuno® is newly formulated, based on past experiences and scientific principles of GCMAF and RERUM®.  Optimized to capitalize on the most bioactive components of GCMAF. Imuno® is a new updated vegan super nutritional supplement and represents a quantum leap when compared to the previous immune support formulas. Simply put imuno® is GcMAF made better through over 25 years of research. 

Call 630-451-8821 or send us email for questions and/or to receive more details on imuno including case studies and details on the significant advantages that imuno has over GCMAF.


imuno® is revolutionary and contains a patented component which is almost twice as effective as comparable formulas.

Some may ask how and why?

The answer is: Through 25 years of research Molecular biologists have identified the most bioactive, immune-boosting, Macrophage activating, Neuro Protective components in GcMAF. Thus the 5th generation formulation of imuno commenced development and is now available as an exciting and brilliant all-natural vegan product far more advanced than the original GCMAF produced out of Japan. 

imuno® is a vegan product,  which especially helps to keep it light and pure. It does not contain any products of animal origin, in contrast to older generation formulas currently sold in Asia.

imuno® is designed by Molecular Biologist,  Dr. Marco Ruggiero, MD. Ph.D.  Author of many peer-reviewed scientific papers on quantum biology and immunotherapy.

Designed in 2018 imuno® is set apart from its predecessors. Its ingredients have been carefully crafted with detailed perfection to deliver a powerful action of supporting the immune system in doing as it should and removing what it doesn't want. Perhaps it is the micro-sized ingredients of chondroitin sulfate, phosphatidylcholine, cholecalciferol which are pure, vegan, and inherent of a low-molecular-weight.  The ingredients work naturally with our body's immune system to create a revolutionary supra-molecular structured delivery system to target and support the immune system's biological intention. 

This novel design allows more efficiency and power using a proprietary algorithm based on biological negentropy.  imuno® cannot be duplicated due to its complex nature of the formulation process.

Benefits of imuno® over GcMAF from Japan

Injectable GcMAF from Japan is manufactured by enzymatically treating filtered serum from human donors. The resulting product has three significant shortcomings.

1. The Japanese product occasionally produces limb immobilizing pain around the injection site. This is likely due to incompatible proteins from the donors blood.
2. Sterile filtered serum (0.22 microns) does not remove the smallest Prions (0.03 microns) that cause neurodegenerative diseases and may be transmitted in serum.
3. The nutritional status of the donor must affect the resulting multimolecular complexes. i.e. serum deficiency of chondroitin sulfate or vitamin D will limit product effectiveness.
4. The Main benefits of GCMAF have now been identified as the Low Molecular weighted Chondroitin Sulfate combined with the Phophilids and not the GC-Protein  as previously thought.
5.  Independent European Laboratory test and report that imuno is about 100 times more effective than pure GcMAF in its ability to inhibit Nagalase.

Note that misinformation regarding GCMAF continues as many books and websites that are still touting the original GCMAF from japan are now quite outdated based on the research and by Dr. Ruggeiro and development of Imuno®.

Using imuno® - The Solution Recommended Dosage

imuno - The Solution® is a sterile solution that comes in a 3 ml vial. Each vial will provide 15 servings at the adult dosage of .2 ml. The maximum dosage of the product is .5 ml. Utilizing imuno at a dosage of .5 ml will yield 6 serving per 3 ml vial.

• The adult serving size: 0.2 ml (4 drops) daily. 
• (maximum dose 0.5 ml daily)
• The child serving size: 0.05 ml (1 drops) to 0.1 ml (2 drops) daily. 
• (maximum dose .25 ml daily)

Chondroitin Sulfate, an ingredient in imuno - The Solution®, has a blood-thinning effect, so when taking large doses, people on anticoagulant drugs, are advised to be under medical supervision. 3ml of imuno^® contains the equivalent of over 120000ng of purified GcMAF.

Quantity discount pricing available! See below for quantity pricing.

Transport: room temperature, protected from light.
Store: refrigerated or cool and dark.
Once opened: store refrigerated (< 8 °C) and closed. If the oral adapter used (membrane wide open) then use contents within 60 days. If a sterile needled syringe is used (membrane intact, contents sterile) then use contents within 24 weeks.

Active Ingredients: VeganChondroitin sulfate, phosphatidylcholine, cholecalciferol. (Other Ingredients: water, salt.)

To keep the vial from contamination, it is advised that you use a sterile syringe to remove the solution and ensure that the inner membrane closure remains intact.  Further, this partially vial can be stored in the refrigerator for up to 8 weeks.  

There is also a "needleless/oral" syringe included which is an alternate way to extract the solution from the vial when used with the oral adapter cap.  A partially used vial should be refrigerated.

Methods of application:

For methods of application please send an email to sales@bravo-probiotic-yogurt.com 

The Protocol

The current "imuno® - The Solution Protocol" includes Bravo Yogurt or Bravo Non-Dairy which work synergistically to move congestion out from deep in the body.  The chondroitin sulfate passes through the deepest congestion and passes the waste up to the mucosa and lymph which the Bravo products help to keep active.  

Imuno® can be administered in many ways. Enclosed are instructions on usage of imuno® with the oral adapter.

1. imuno® is a sterile, slightly thick and cloudy liquid of indistinct taste and may be used as an oral dietary supplement.
2. Shake the vial vigorously and then prise the plastic flip-top disk from the top of the vial.
3. Remove the paper backing from the vial adapter and push the vial into the vial adapter. The plastic spike will pierce the grey stopper visible in the centre of the metal top, and the adapter will clip into place. Remove the vial and the installed adapter from the plastic packaging.
4. Push the closed syringe firmly into the top of the vial adapter (depressing the blue rubber valve)
5. Invert the vial with syringe underneath and draw the syringe open to the required amount (i.e. 0.2 ml).
6. Remove the syringe from the vial adapter. The valve will close and seal the vial/adapter on syringe removal. Store the vial upright.
7. Use the required dose from the syringe.

 

 

See our Video on How to Load Supplied Needleless Syringe When taking the product orally

Significant Scientific Articles

• 2019 Oct, Color Doppler Evaluation of Isovolumetric Relaxation Time and of Signals Arising from Axons of the Median Nerve as a Means to Evaluate Mitochondrial Functionality in the Context of Immunotherapy of Cancer and Chronic Conditions Associated with Mitochondrial Dysfunction.
  Link to Publisher
  Download Full Article
• 2019 Jun, Use of an Extremely Biodiverse Probiotic [Bravo] and a Supplement Based on Microbial Chondroitin Sulfate [imuno] is Associated with a Significant Decrease of Serum Free Kappa Light Chains as well as a Trend Toward Normalization of Kappa/Lambda Ratio and of Plasma Cell Bone Marrow Infiltration in a Case of Multiple Myeloma [complete remission].
  Link to Publisher
  Download Full Article
• 2019 Apr, Tailoring the Ruggiero-Klinghardt Protocol to Immunotherapy of Autism [with imuno].
  Link to Publisher
  Download Full Article
• 2019 Feb, Clinical Experience of Integrative Autism treatment with a Novel type of Immunotherapy.
  Link to Publisher
  Download Full Article
• 2018 Sep, A Novel potential Adjuvant for Cancer Vaccines.
  Link to Publisher
  Download Full Article
• 2018 Sep, Rationale for the design of a novel tool for immunotherapy based on an emulsion of glycosaminoglycan.
  Link to Publisher
  Download Full Article
  View as HTML

GcMAF Theory Inconsistencies
In 2008, it was shown that some humans are genetically unable to produce one single molecule of GcMAF, but despite this fact, the risk of cancer in these individuals is decreased rather than increased (25). And in 2009, it was shown that there was no significant depletion of internal GcMAF in cancer patients and that the internal GcMAF was actually much higher than the amount of GcMAF being administered in the immunotherapy. These observations clearly disprove the theory that can-cer patients have decreased production of internal GcMAF, or that decreased levels of GcMAF create
immunodeficiency. So how can it be that several research groups and many clinical case reports have reported consistently positive results, utilizing small doses of GcMAF?

In order to solve the inconsistencies, an alternative theory was proposed, that the chondroitin sulfate attached to GcMAF is responsible for the biological action attributed to GcMAF .

How Does GcMAF Actually Work?
GcMAF binds to a variety of cells that include the immune system, but a GcMAF cellular receptor has never been found or described in molecular detail .
 Gc Protein instead binds in chains (oligomer) with Chondroitin Sulfate on the cell surface .
 Chondroitin Sulfate is composed of a chain of alternating sugars (GalNAc and glucuronic acid).
 The biological and clinical effects of GcMAF are actually due to the Chondroitin Sulfate (with its GalNAc which is the supposed active site of GcMAF) and its association with lipophilic compounds.

GcMAF Made Better
In 2015 Rerum® was released. This product was based on animal-sourced Chondroitin Sulfate and its efficacy as a replacement for GcMAF was established with clinical case reports . Then in 2018 Rerum® was superseded by imuno®.

imuno® is based on vegan, ultra-pure, homogeneous, low-molecular-weight Chondroitin Sulfate, complexed with ultra-pure Phosphatidylcholine and Vitamin D3. imuno® was designed as a substantial improvement over GcMAF and Rerum® and empowered with all their biological effects and more. On one side, we have the known health effects of its components, that are amplified by their assembly in a multi-molecular structure held together by a higher number of non-covalent bonds and on the other side, the physical-chemical features of the emulsion enable imuno® to function in a manner superimposable to that of Freund’s adjuvants. 

It has been theorized that the highly negatively charged chondroitin sulfate in Imuno may have an effect to bind to the positively charges spiked protein molecules in the Corona-Virus. This might have an effect to support making the corona-virus innate in its ability to bind to human receptor cells. Don't hesitate to ask for research!

Click Here to listen to broadcast